Replies to post #106977 on Biotech Values

[zipjet]

Q3 will have the revenue from the $292M in sales.

But keep in mind that revenue to MNTA is very different than revenue to NVS. MNTA revenue will be more comparable to gross margin less certain expenses at the NVS level.

I have no reason to question DD's statements on when cash will flow. But we will see it in black and white soon enough.

ij